This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

5 alpha reductase inhibitors and depression

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

5-alpha reductase inhibitors and depression

A register-based prospective cohort study in Sweden comprising 2,236,876 men found that

  • while 5-ARIs (5 alpha-reductase inhibitors) were associated with increased risk for all-cause dementia, Alzheimer disease, and vascular dementia after the start of treatment, the association became statistically insignificant over 4 years of exposure
  • was no association between 5-ARIs and suicide, but both finasteride and dutasteride were associated with an increased risk for depression

The study authors concluded that:

  • 5 alpha reductase inhibitors might cause depression

Reference:

  • Garcia-Argibay M, Hiyoshi A, Fall K, Montgomery S. Association of 5 alpha - Reductase Inhibitors With Dementia, Depression, and Suicide. JAMA Netw Open. 2022;5(12):e2248135. doi:10.1001/jamanetworkopen.2022.48135

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.